AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 194 filers reported holding AXSOME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,177,077 | +10.5% | 531,937 | +13.7% | 0.11% | +8.0% |
| Q2 2023 | $33,630,696 | -53.4% | 468,003 | -60.0% | 0.10% | -55.2% |
| Q1 2023 | $72,154,929 | +43.9% | 1,169,827 | +80.0% | 0.22% | +31.2% |
| Q4 2022 | $50,139,513 | +81.9% | 650,065 | +5.2% | 0.17% | +54.5% |
| Q3 2022 | $27,571,000 | +1623.2% | 617,900 | +1379.1% | 0.11% | +1471.4% |
| Q2 2022 | $1,600,000 | -33.2% | 41,775 | -1.2% | 0.01% | -36.4% |
| Q1 2021 | $2,395,000 | -62.1% | 42,300 | -45.4% | 0.01% | -64.5% |
| Q4 2020 | $6,314,000 | -2.2% | 77,500 | -14.5% | 0.03% | -6.1% |
| Q3 2020 | $6,459,000 | -69.7% | 90,657 | -65.1% | 0.03% | -76.3% |
| Q2 2020 | $21,343,000 | -47.0% | 259,397 | -62.1% | 0.14% | -57.5% |
| Q1 2020 | $40,255,000 | +1143.2% | 684,254 | +327.7% | 0.33% | +1535.0% |
| Q3 2019 | $3,238,000 | +359.3% | 160,000 | -36.0% | 0.02% | +566.7% |
| Q4 2018 | $705,000 | – | 250,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
| Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
| Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
| RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
| SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
| BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
| Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
| Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
| Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |